Lbh589: Clinical Trials

1 trial of Lbh589, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow Lbh589: new trials by email Literature Review of Lbh589 trials Research Report on Lbh589

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CINC424A2X01B Rollover Protocol
ruxolitinib, panobinostat - Primary Myelofibrosis, Polycythemia Vera
Phase 4Active not recruitingNovartis Pharmaceuticals2792015-03-052026-10-19

Conditions studied

Bronchiolitis Obliterans Syndrome (1)  ·  Graft vs Host Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Polycythemia Vera (1)  ·  Primary Myelofibrosis (1)  ·  Thalassemia (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)

NIH funding

2014 (1)